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Bell: Handbook of Bioentrepreneurship (Book Review)

Book Review
Handbook of Bioentrepreneurship

Joseph R. Bell
Holger Patzelt and Thomas Brenner, eds., Handbook of
Bioentrepreneurship, New York: Springer, 2008, 294
pages. $139.

he Handbook of Bioentrepreneurship, edited by
Holger Patzelt, of the Max Planck Institute of
Economics, and Thomas Brenner, of Philipps
University Marburg, represents volume 4 in the International
Handbook Series on Entrepreneurship.This book is a collection of articles covering the rapidly evolving biotechnology
industry. The editors point out that biotechnology exemplifies entrepreneurial activity and is driven by “high knowledge
intensity, long product development cycles, high technological and market uncertainties, and an extraordinary need for
capital” (page 2). This book is not for the timid or casual reader of entrepreneurship, but for those with a compelling interest in biotechnology.The editors suggest the book is geared
more toward the academic reader rather than practitioners.
In chapter one, the editors establish the purpose of the
book as twofold: First, to provide an overview of the current
state of the academic field; and second, to identify gaps within the current research and offer suggestions as to how future
research might be approached.The following 11 chapters are
organized into four parts: (1) the geography of biotechnology
and regional networks, (2) strategic and managerial perspectives, (3) university bioentrepreneurship, and (4) legal frameworks and bioentrepreneurship policy (page 3).
The second chapter provides incredible insight into the
worldwide biotechnology industry and offers an in-depth
analysis of its economics. At times, throughout the entire
book it seems appropriate to utter the word “fascinating.” For
its part, this chapter presents a comprehensive, eye-opening
review of the industry through comparative tables of its economics, the product pipeline and development stage, industry demographics, and key biotechnology clusters.
Chapters three and four focus on social and innovation
networks. Both chapters validate the importance of the role
that universities play in the formation of biotechnology
firms. Some of the conclusions were quite surprising and
made for interesting reading. Chapter four (pages 57–58)

T

presents a discussion of how the roles between universities
and biotechnology firms have begun to blur.Today, universities and biotechnology firms have ventured into what was
once a more clearly delineated stance regarding fundamental
and applied research. This essential and timely discussion
begins to paint a picture as to the future of the biotechnology industry and changes currently taking place in the pharmaceutical marketplace.1
Chapter five, entitled “Strategy and Strategic Thinking in
Biotechnology Entrepreneurship,” is relatively short (17
pages), but again provides a fascinating look at strategic planning for biotechnology firms. Some observations, such as
how the gap between strategy and entrepreneurship has
begun to close, and the importance of a reimbursement strategy, make this short but compelling chapter some of the best
reading in the book.
The authors discuss in chapter six why strategic alliances
are important and how some of the best alliances are formed.
This section is comprehensive and provides insights into
many underlying factors that drive organizations to form
alliances.The chapter is also a wealth of interesting evidencebased trivia including, “of every 10,000 compounds
screened, only five will enter clinical testing and only one
will receive FDA approval” (page 107), and that alliances are
far more likely to form if “their founders have graduated from
the same educational institution” (page 110).
Chapter seven continues by discussing strategic and managerial perspectives of mergers and acquisitions. It is especially informative in exposing both reasons and motives for merger and acquisition activities in the biotechnology industry.
Chapter eight offers an intriguing case study of Kirin
Brewery Company of Japan and how it went from brewing
beer to developing and marketing biopharmaceuticals. The
case illustrates a practical example of the strategic and managerial perspectives covered in the previous chapters.
Chapter nine touches on why some university scientists
commercialize and why others do not.The chapter is a very
enlightening piece supported by reference to some of entrepreneurship’s top researchers, past and present.The chapter
also addresses how the age of the researcher plays a role in
their desire to commercialize—somewhat counter to what
you might first expect.
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Chapter 10 addresses the “recent phenomenon”of university-based spin-offs. It is outstanding in identifying contemporary issues facing spin-offs, the biotechnology industry, and
research scientists. It also presents an informative discussion
on the strategies employed by institutions to create and support the “entrepreneurial scientist”(page 198). Continuing on
the topic of university biotechnology, Chapter 11 offers a
detailed assessment of the current state of patenting, the
uniqueness and challenges of patenting biotechnology, and
importantly, the patent strategies employed by researchers
and universities.
The final chapter,“Legal Frameworks and Public Support
in the Biotechnology Industry” sounds interesting but serves
as a bit of a letdown with an extensive discussion on the
issues as they affect the country of Germany. At times, the
same limitation could be mentioned for a number of the
other chapters, but those chapters seem to provide enough
industry-wide coverage to overcome a country- or regionspecific perspective.
In conclusion, the book presents a history of bioentrepreneurship, including comprehensive industry statistics and
insightful strategies for the biosciences and entrepreneurship. The book is well organized, contains a comprehensive
index, and without exception, each of the articles is extremely well written.

Merriam Webster defines a “handbook” as “a book capable
of being conveniently carried as a ready reference,” or “a concise reference book covering a particular subject” (2009
Merriam Webster Online Search).The book’s title is a bit of a
misnomer, for I anticipated reviewing a “handbook.” Instead,
the Handbook of Bioentrepreneurship is neither a reference, nor concise, but it does serve as an in-depth discussion,
though at times an academic approach, to the biosciences
and entrepreneurship. And, as with any publication addressing an industry with explosive growth and ongoing change,
some of the data can become quickly dated. These minimal
considerations aside, the book is an interesting read and
establishes a compelling factual perspective for the biotechnology industry.
The audiences best served by the book are academicians,
doctoral students, and possibly specialized masters’ students
with an interest in, or need to understand the concept of,
bioentrepreneurship. The chapters do waver at times
between theory and practicality, but in my current role as a
practitioner of biotechnology, I uttered the word “fascinating” far too often to suggest a lack of practitioner interest in
the book. Fall into one of these categories and the book is
definitely recommended a must-read.

Endnote
1.A February 2009 Fast Company magazine article (pages 36–39) entitled “Grand Experiment” discussed the success of drugmaker Wyeth Pharmaceuticals (BioPharma) and stressed that its success stemmed from a research culture being “almost like academia.”At the time of this review Pfizer, Inc. was in the process of acquiring Wyeth for $68 billion.
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